Publication|Articles|August 1, 1996

July/August 1996
Volume 2
Issue 7

Gatekeepers and Managed Care: Too Much of a Good Thing?

Author(s)J. Sanford Schwartz, MD, Allan Hillman, MD, MBA

Download PDF: Gatekeepers and Managed Care: Too Much of a Good Thing?

Articles in this issue

almost 30 years ago

Article

Correspondence regarding, "Intended and Unintended Consequences of HMO Cost-Containment Strategies: Results from the Managed Care Outcomes Project"

almost 30 years ago

Article

Correspondence regarding, "Ethics in Managed Care: The Obligation of Administration to Attending Consequences"

almost 30 years ago

Article

Process and Outcome of Outpatient Management of Heart Failure: A Comparison of Cardiologists and Primary Care Providers

almost 30 years ago

Article

Understanding the Behavioral Response to Medical Innovation

almost 30 years ago

Article

Cost Comparison of Induction of Labor Versus Expectant Management in Pregnancies Lasting Longer Than 41 Weeks

almost 30 years ago

Article

Respiratory Syncytial Virus Immune Globulin: A Cost-Effectiveness Analysis

almost 30 years ago

Article

Improving Patient Satisfaction with Warfarin Management

almost 30 years ago

Article

The Third Generation of Managed Care

almost 30 years ago

Article

Results of a Smoking-Cessation Program in a Managed Care Setting

almost 30 years ago

Article

Breast Cancer Screening: Who, When, and How

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

ByJason Bartock, MD,Adam Green, MD,Raquel Nahra, MD,Amy Bordogna, MD,Amir Davoodi, MD,Jean-Sebastien Rachoin, MD

June 11th 2026

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

ByDana R. Fletcher, PhD,Lisa M. Sandy, MA,Joy Waughtal, MPH,Cole Hoffman, MS,Sylvie Novins-Montague, BA,Patrick Hosokawa, MS,Pamela N. Peterson, MD, MSPH,Larry A. Allen, MD, MPH,Sheana Bull, PhD,P. Michael Ho, MD, PhD

June 10th 2026

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

ByRazanne Oueini, PharmD,Ben Shirley, BS,Christie Teigland, PhD,Melissa Castora-Binkley, PhD, MA,Scott Bilder, PhD,Kiran Sunkari, MS,Lynn Pezzullo, RPh

June 8th 2026

US map with stethoscope | Image Credit: © Andreas Prott - stock.adobe.com

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

ByShifeng Wu, MM

June 5th 2026

Health Care Utilization in Veterans With Alzheimer Disease

ByYing Wang, PhD,Byron J. Aguilar, PhD,Mingfei Li, PhD,Peter Morin, MD, PhD,Joel Reisman, BS,Wen Hu, MS,Jong Soo Lee, PhD,Dan Berlowitz, MD, MPH,Qinqing Li, MS,Raymond Zhang, PhD,Amir Abbas Tahami Monfared, MD, PhD,Quanwu Zhang, PhD,Weiming Xia, PhD

June 4th 2026

Gatekeepers and Managed Care: Too Much of a Good Thing?

Articles in this issue

Related Content

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

Health Care Utilization in Veterans With Alzheimer Disease

Trending on AJMC

Tec-Dara Demonstrates Superior 3-Year PFS vs Standard Therapy in Functional High-Risk Myeloma: Rahul Banerjee, MD

MRD-Guided CLL Treatment Duration: Personalization or Malpractice?

Global Hematology Trials Ensure Research Stays Applicable, Flexible, Patient-Centered

Blinatumomab Improves Outcomes, Toxicity in High-Risk Pediatric ALL: Martin Schrappe, MD, PhD

CLL14 Frontline Combo Results Bolstered by Real-World Outcomes